Business / Finance

RSS

New booklet helps researchers decide about conducting clinical trials in Asia-Pacific region

A new booklet from Theorem Clinical Research is now available to help researchers at medical device companies decide if they want to conduct clinical trials in the Asia-Pacific region, and, if so, in what countries.

9 Oct 2013

Nuventra launches innovative software platform for conducting population PK analyses

Nuventra Pharma Sciences, a specialty pharmaceutical consulting firm with global reach, is pleased to announce the launch and availability of an innovative software platform called Darwin for conducting population pharmacokinetic (PK) analyses based on a genetic algorithm paradigm.

9 Oct 2013

Healios K.K. successfully raised its target capital of 3 billion JPY (USD $30.6 million)

Healios K.K. (Headquarters: Tokyo, Japan; President and CEO: Hardy TS Kagimoto M.D.), a Japanese bioventure company at the forefront of developing innovative therapies utilizing human induced pluripotent stem cell (hiPSC) technology, is pleased to announce that it has successfully raised its target capital of 3 billion JPY (USD $30.6 million).

9 Oct 2013

Saint Luke's Health System launches doxo to enhance quality of services

Saint Luke's Health System and doxo today announced Saint Luke's Health System has launched doxo across all ten of its hospitals to expand patients' electronic access to their billing information.

9 Oct 2013

Francisco Partners invests in NexTech

Francisco Partners, a leading technology-focused private equity firm, today announced a strategic investment in NexTech, a leading provider of fully integrated electronic medical records, practice management, and marketing software solutions for specialty physician practices. Closing is subject to customary conditions, including Hart-Scott-Rodino clearance.

9 Oct 2013

Ramsell partners with Alameda County to provide pharmacy benefits management services

Ramsell, a leading provider of innovative solutions for organizations that serve the underserved, today announced a new partnership with Alameda County Behavioral Health Care Services to provide pharmacy benefits management services to more than 900 low-income mental health patients.

9 Oct 2013

Laborie acquires UroMed's pelvic muscle rehabilitation business

Laborie Medical Technologies, Inc., a portfolio company of Audax Group, announced it has completed the acquisition of UroMed Technology, Inc.'s pelvic muscle rehabilitation business.

9 Oct 2013

Quintiles and MDA partner to develop U.S. Neuromuscular Disease Registry

Quintiles and the Muscular Dystrophy Association (MDA) today announced a new partnership to develop and implement the U.S. Neuromuscular Disease Registry, a patient registry that will play an important role in determining effective treatments for people with muscular dystrophy and related muscle diseases.

9 Oct 2013

Bariatric Advantage announces new decaffeinated version of Pro Joe Magnifico Mocha

Bariatric Advantage today announced that bariatric patients now have another option to increase their daily protein intake with the new decaffeinated version of Pro Joe Magnifico Mocha.

9 Oct 2013

AdvantEdge Healthcare launches QualityEdge information capture service

AdvantEdge Healthcare Solutions, one of the nation's leading providers of medical billing, practice management, and coding services for specialty physicians, hospitals, and surgery centers, is launching its QualityEdgeSM information capture service, which allows physicians and other providers to easily capture data that would otherwise require paper notes or the use of an EMR.

9 Oct 2013

Net income of Biomet increased 33.8% to $80.8M in first quarter of 2014

Biomet, Inc. announced today financial results for its first quarter ended August 31, 2013.

9 Oct 2013

Boehringer Ingelheim’s interim data from Phase II HCV clinical collaboration with Presidio Pharmaceuticals accepted for presentation at AASLD

Boehringer Ingelheim today announced that interim data from its Phase II hepatitis C (HCV) clinical collaboration with Presidio Pharmaceuticals have been accepted for presentation as a late breaker poster at the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place 1-5 November in Washington, D.C. (1) The poster presentation will be on Monday 4 November.

8 Oct 2013

J&J's Janssen Buys Rights To Hepatitis C Compound From GSK

...

8 Oct 2013

Clinical Genomics Nabs Enterix, Aims To Launch New Bowel Cancer Blood Test

...

8 Oct 2013

MedShape closes $11 million in new financing

MedShape, Inc., the industry leader in shape memory orthopedic devices, today announced the closing of $11 million in new financing. The investment will help drive further development and commercialization of pipeline products, including the full market release of the Eclipse Soft Tissue Anchor, MedShape's newest shape memory fixation device for soft tissue repair.

8 Oct 2013

Eddingpharm Secures Immutep’s Immufact IMP321 For Growing Stable

Eddingpharm continued to aggressively build its product portfolio by inking another cancer agreement, this time with Immutep. In this latest agreement, Eddingpharm was granted exclusive rights to develop and market ImmuFact® IMP321 in mainland China, Hong Kong, Macau, and Taiwan.

7 Oct 2013

Immutep, Eddingpharm partner to develop and commercialize ImmuFact IMP321

Immutep S.A., the biopharmaceutical company specializing in immuno-oncology, and Eddingpharm have entered into an agreement regarding the development, commercialization and manufacturing of Immutep’s ImmuFact IMP321.

7 Oct 2013

Advantages of on-site analytical laboratories outlined in new white paper from PCI

PCI, a global supplier of pharmaceutical commercial packaging solutions and clinical trials services, announces the availability of a white paper detailing the advantages of having on-site analytical laboratories in order to meet the needs of the pharmaceutical industry.

From Packaging Coordinators Inc. (PCI) 7 Oct 2013

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.

7 Oct 2013

Boreal Genomics announces completion of $18 million Series C financing round

Boreal Genomics, a privately held provider of technology for non-invasive genomic profiling of tumors from blood plasma of cancer patients, announced today the completion of an $18 million Series C financing round.

5 Oct 2013

Business / Finance

New booklet helps researchers decide about conducting clinical trials in Asia-Pacific region

Nuventra launches innovative software platform for conducting population PK analyses

Healios K.K. successfully raised its target capital of 3 billion JPY (USD $30.6 million)

Saint Luke's Health System launches doxo to enhance quality of services

Francisco Partners invests in NexTech

Ramsell partners with Alameda County to provide pharmacy benefits management services

Laborie acquires UroMed's pelvic muscle rehabilitation business

Quintiles and MDA partner to develop U.S. Neuromuscular Disease Registry

Bariatric Advantage announces new decaffeinated version of Pro Joe Magnifico Mocha

AdvantEdge Healthcare launches QualityEdge information capture service

Net income of Biomet increased 33.8% to $80.8M in first quarter of 2014

Boehringer Ingelheim’s interim data from Phase II HCV clinical collaboration with Presidio Pharmaceuticals accepted for presentation at AASLD

J&J's Janssen Buys Rights To Hepatitis C Compound From GSK

Clinical Genomics Nabs Enterix, Aims To Launch New Bowel Cancer Blood Test

MedShape closes $11 million in new financing

Eddingpharm Secures Immutep’s Immufact IMP321 For Growing Stable

Immutep, Eddingpharm partner to develop and commercialize ImmuFact IMP321

Advantages of on-site analytical laboratories outlined in new white paper from PCI

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

Boreal Genomics announces completion of $18 million Series C financing round

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News